The following lists Alzheon's accounts (pages) on major social platforms, including Facebook, Twitter, Youtube, LinkedIn, etc. You can find the support information (solution) of related problems through these social pages, and you can also use Alzheon's support phone number, support email, or direct access to all Alzheon customer service contacts.
Alzheon Overview
Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candidate, ALZ-801, is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain. ALZ-801 is an easy-to-take tablet that builds on the safety and efficacy profile of its active compound tramiprosate, which has been evaluated in clinical trials involving over 2,000 Alzheimer’s patients. Our clinical expertise and technology platform are focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients. www.alzheon.com
| Industry | Biotechnology Research |
| Headquarters | Framingham, MA |
| Company size | 11-50 employees |
| Website | http://www.alzheon.com |